推荐产品
质量水平
方案
≥98% (HPLC)
表单
powder
储存条件
desiccated
颜色
white to beige
溶解性
H2O: 2 mg/mL, clear
储存温度
2-8°C
SMILES字符串
OC(COC1=CC=CC(C)=C1)CNCCC2=CC(OC)=C(C=C2)OC.Cl
InChI
1S/C20H27NO4.ClH/c1-15-5-4-6-18(11-15)25-14-17(22)13-21-10-9-16-7-8-19(23-2)20(12-16)24-3;/h4-8,11-12,17,21-22H,9-10,13-14H2,1-3H3;1H
InChI key
FJTKCFSPYUMXJB-UHFFFAOYSA-N
生化/生理作用
Bevantolol is orally available, anti-hypertension agent that acted as both a beta blocker and a calcium channel blocker. Bevantolol is a beta 1 (β1) adrenoceptor antagonist with alpha1 (α1)-adrenoceptor partial antagonist activity. Bevantolol had no effect on the beta-adrenoceptor density and their subtype proportions after chronic administration in rats.
orally available, anti-hypertension agent that acted as both a beta blocker and a calcium channel blocker; β1- and α1- adrenoceptor antagonist
警示用语：
Warning
危险声明
危险分类
Acute Tox. 4 Oral
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
新产品
历史批次信息供参考:
Gavin W K Wong et al.
The Cochrane database of systematic reviews, 3, CD007451-CD007451 (2016-03-11)
Beta blockers are commonly used to treat hypertension. The blood pressure reading is the primary tool for physicians and patients to assess the efficacy of the treatment. The blood pressure lowering effect of beta-1 selective blockers is not known. To
Takahiro Horinouchi et al.
Life sciences, 81(5), 399-404 (2007-07-14)
Recently, tissue segment binding method with a hydrophilic radioligand [(3)H]-CGP12177 was developed to detect plasma membrane beta-adrenoceptors in rat heart (Horinouchi et al., 2006). In the present study, propranolol (40 mg kg(-1) day(-1)), atenolol (40 mg kg(-1) day(-1)) and bevantolol
Barbara Malinowska et al.
British journal of pharmacology, 139(8), 1548-1554 (2003-08-19)
1. Atypical beta-adrenoceptors resistant to propranolol, but blocked by bupranolol, increase contractile force and/or frequency of the heart in humans and rats. We compared the potencies of the enantiomers of bupranolol and examined the possible effects of seven bupranolol analogues
David J Augeri et al.
Journal of medicinal chemistry, 48(15), 5025-5037 (2005-07-22)
Efforts to further elucidate structure-activity relationships (SAR) within our previously disclosed series of beta-quaternary amino acid linked l-cis-4,5-methanoprolinenitrile dipeptidyl peptidase IV (DPP-IV) inhibitors led to the investigation of vinyl substitution at the beta-position of alpha-cycloalkyl-substituted glycines. Despite poor systemic exposure
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门